Study on the efficacy of atorvastatin as an adjuvant therapy for hypertension combined with hyperlipidemia
阿托伐他汀辅助治疗高血压合并高血脂的疗效探讨

摘要

目的 分析阿托伐他汀辅助治疗高血压合并高血脂产生的效果。方法 选择我中心2020年1月至2022年1月接收的60例高血压合并高血脂患者为研究对象，将其按照随机数表方式分组，分为对照组和观察组，各组均为30例。对照组实施常规治疗，观察组在对照组基础上加入阿托伐他汀辅助治疗。对比两组治疗效果差异。结果 观察组SBP、DBP明显低于对照组；观察组TC、TG、LDL-C水平明显低于对照组，HDL-C水平明显高于对照组；观察组治疗总有效率明显高于对照组（P<0.05）均为差异显著，有统计学意义。结论 阿托伐他汀辅助治疗高血压合并高血脂的疗效显著，能够有效控制血脂、血压，值得临床重视并大力推广。

Abstract

Objective To analyze the effectiveness of atorvastatin in the adjuvant treatment of hypertension with hyperlipidemia.
Methods Sixty patients with hypertension and hyperlipidemia admitted to our hospital from January 2020 to January 2022 were selected as the research subjects. They were randomly divided into a control group and an observation group, with 30 cases in each group. The control group received routine treatment, while the observation group received adjuvant therapy with atorvastatin on top of the control group. Compare the differences in treatment effects between the two groups.
Results The SBP and DBP in the observation group were significantly lower than those in the control group; The levels of TC, TG, LDL-C in the observation group were significantly lower than those in the control group, while the levels of HDL-C were significantly higher than those in the control group; The total effective rate of the observation group was significantly higher than that of the control group (P<0.05), indicating significant differences and statistical significance.
Conclusion   Atorvastatin has a significant therapeutic effect on hypertension combined with hyperlipidemia, and can effectively control blood lipids and blood pressure. It is worthy of clinical attention and vigorous promotion.